These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 33753502
1. Gain-of-function factor H-related 5 protein impairs glomerular complement regulation resulting in kidney damage. Malik TH, Gitterman DP, Lavin DP, Lomax-Browne HJ, Hiemeyer EC, Moran LB, Boroviak K, Cook HT, Gilmore AC, Mandwie M, Ahmad A, Alexander IE, Logan GJ, Marchbank KJ, Bradley A, Pickering MC. Proc Natl Acad Sci U S A; 2021 Mar 30; 118(13):. PubMed ID: 33753502 [Abstract] [Full Text] [Related]
2. Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy. Márquez-Tirado B, Gutiérrez-Tenorio J, Tortajada A, Lucientes Continente L, Caravaca-Fontán F, Malik TH, Roldán Montero R, Elías S, Saiz Gonzalez A, Fernández-Juarez G, Sánchez-Corral P, Pickering MC, Praga M, Rodríguez de Córdoba S, Goicoechea de Jorge E. J Am Soc Nephrol; 2022 Jun 30; 33(6):1137-1153. PubMed ID: 35545301 [Abstract] [Full Text] [Related]
3. Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies. Loeven MA, Maciej-Hulme ML, Yanginlar C, Hubers MC, Kellenbach E, de Graaf M, van Kuppevelt TH, Wetzels J, Rabelink TJ, Smith RJH, van der Vlag J. Front Immunol; 2021 Jun 30; 12():676662. PubMed ID: 34489931 [Abstract] [Full Text] [Related]
11. Partial Complement Factor H Deficiency Associates with C3 Glomerulopathy and Thrombotic Microangiopathy. Vernon KA, Ruseva MM, Cook HT, Botto M, Malik TH, Pickering MC. J Am Soc Nephrol; 2016 May 01; 27(5):1334-42. PubMed ID: 26374608 [Abstract] [Full Text] [Related]
12. Liver factor B silencing to cure C3 glomerulopathy: Evidence from a mouse model of complement dysregulation. Zanchi C, Locatelli M, Corna D, Cerullo D, Fishilevich E, Desai D, Rottoli D, Donadelli R, Noris M, Zoja C, Remuzzi G, Benigni A. Mol Immunol; 2023 Sep 01; 161():25-32. PubMed ID: 37481826 [Abstract] [Full Text] [Related]
13. Complement and glomerular disease: new insights. Pickering M, Cook HT. Curr Opin Nephrol Hypertens; 2011 May 01; 20(3):271-7. PubMed ID: 21422921 [Abstract] [Full Text] [Related]
16. C3 glomerulonephritis and CFHR5 nephropathy. Gale DP, Maxwell PH. Nephrol Dial Transplant; 2013 Feb 01; 28(2):282-8. PubMed ID: 23125424 [Abstract] [Full Text] [Related]
17. Homodimeric Minimal Factor H: In Vivo Tracking and Extended Dosing Studies in Factor H Deficient Mice. Kamala O, Malik TH, Hallam TM, Cox TE, Yang Y, Vyas F, Luli S, Connelly C, Gibson B, Smith-Jackson K, Denton H, Pappworth IY, Huang L, Kavanagh D, Pickering MC, Marchbank KJ. Front Immunol; 2021 Feb 01; 12():752916. PubMed ID: 34956184 [Abstract] [Full Text] [Related]
18. [Characteristics of pediatric C3 glomerulopathy with decreased factor H in 3 cases]. He RJ, Xiao HJ, Wang SX, Guan N, Yao Y, Ding J. Zhonghua Er Ke Za Zhi; 2012 Dec 01; 50(12):939-43. PubMed ID: 23324154 [Abstract] [Full Text] [Related]
19. A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry. Medjeral-Thomas N, Malik TH, Patel MP, Toth T, Cook HT, Tomson C, Pickering MC. Kidney Int; 2014 Apr 01; 85(4):933-7. PubMed ID: 24067434 [Abstract] [Full Text] [Related]
20. Prevention of Fatal C3 Glomerulopathy by Recombinant Complement Receptor of the Ig Superfamily. Wang X, Van Lookeren Campagne M, Katschke KJ, Gullipalli D, Miwa T, Ueda Y, Wang Y, Palmer M, Xing G, Song WC. J Am Soc Nephrol; 2018 Aug 01; 29(8):2053-2059. PubMed ID: 29895552 [Abstract] [Full Text] [Related] Page: [Next] [New Search]